Edit |   |
---|---|
Antigenic Specificity | EGFL7, Human (Parsatuzumab biosimilar) |
Clone | Parsatuzumab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | Block |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human EGFL7 Recombinant Antibody. Parsatuzumab (INN) is a humanized monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to EGFL7. This drug was developed by Genentech/Roche. |
Immunogen | n/a |
Other Names | Anti-EGFL7 Recombinant Antibody, Research Grade Parsatuzumab, Anti-Human EGFL7 Recombinant Antibody, RG7414, RO5490248, Antibody Drug Analogues, Monoclonal Antibody, YR1287, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1312797-14-0 |
Catalog # | YR1287 |
Price | please inquire |
Order / More Info | EGFL7, Human (Parsatuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |